Company Profile For Roche Holding AG

Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company’s products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company’s Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.

BRIEF: For the six months ended 30 June 2009, Roche Holding Ltd.'s total revenue increased 10% to SF24.01B. Net profit for the period decreased 28% to SF3.47B. Total revenue reflects an increase in sales of the Company's products and services in the Pharmaceuticals and the Diagnostics business divisions. Net profit for the period was offset by higher marketing and distribution and research and development expenses.

Roche Holding AG
Grenzacherstrasse 124
Basel     4070
P: +4161.6881111
F: +4161.6919391

80000